Press Releases

Press Releases

Press Releases

Date Title and Summary Additional Formats
May 30, 2018
Genomic Health to Present at Jefferies 2018 Global Healthcare Conference
REDWOOD CITY, Calif. , May 30, 2018 /PRNewswire/ --  Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the Jefferies 2018 Global Healthcare Conference in New York City on Wednesday, June 6, 2018 at 8:30 a.m. Eastern Time . To access the live and subsequently archived
May 21, 2018
New Data Reinforce Positive Impact of the Oncotype DX® Genomic Prostate Score™ Test in Guiding Treatment Decisions
Studies in Over 30,000 Newly Diagnosed Prostate Cancer Patients Presented at American Urological Association (AUA) Annual Meeting Confirm Utility of GPS™ Test in Optimizing Cancer Care REDWOOD CITY, Calif. , May 21, 2018 /PRNewswire/ -- Genomic Health , Inc. (NASDAQ: GHDX) today announced results
May 09, 2018
Genomic Health to Present at Bank of America Merrill Lynch 2018 Health Care Conference
REDWOOD CITY, Calif. , May 9, 2018 /PRNewswire/ --  Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas on Wednesday, May 16, 2018 at 3:00 p.m. Pacific Time .
May 02, 2018
Genomic Health Announces First Quarter 2018 Financial Results and Reports Recent Business Progress
Reported Record Revenue of $92.6M and Delivered 13 Percent Revenue Growth on a Pre-606 Adjusted Basis
Reported Net Loss of $3.8M Including First Quarter Charge of $8.5M for Realignment of Resources
Delivered $4.6M Profit on a Non-GAAP Basis
Apr 26, 2018
Large Independent Study Using the Oncotype DX® Test Accepted for Presentation at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
REDWOOD CITY, Calif. , April 26, 2018 /PRNewswire/ --  Genomic Health, Inc.  (NASDAQ: GHDX) has been informed of the acceptance of the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, for presentation by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).
Apr 25, 2018
Genomic Health to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 2, 2018
REDWOOD CITY, Calif. , April 25, 2018 /PRNewswire/ -- Genomic Health , Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Wednesday, May 2 at 4:30 p.m. Eastern Time to discuss its first quarter 2018 financial results. The call and webcast will follow the
Mar 15, 2018
Landmark TAILORx Results Aid in Assessing the Effect of Chemotherapy in Women with Early-stage Breast Cancer and Oncotype DX Breast Recurrence Score® Results of 11 to 25
Results from Large, Prospective Randomized Clinical Trial to be Submitted for Presentation at Upcoming Major Medical Meeting
Mar 08, 2018
Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook
Achieved $1.9M Profit in the Fourth Quarter; Reported Net Loss of $3.9M for the Full Year
Delivered $0.4M Full-year Profit on a Non-GAAP Basis Excluding Business Development Transaction Costs
Delivered 7 Percent Test Growth and 6 Percent Revenue Growth in the Fourth Quarter
Guides to Double-digit Revenue Growth and Full-year Profitability in 2018
Feb 26, 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX® AR-V7 Nucleus Detect™ Test to Predict Treatment Response in Metastatic Disease
New Liquid Biopsy Test Helps Physicians Select Most Effective Treatment, Prolonging Lives of Men with Metastatic Castration-resistant Prostate Cancer
Feb 22, 2018
Genomic Health to Announce Fourth Quarter and Year-End 2017 Financial Results and Host Conference Call on Thursday, March 8, 2018
REDWOOD CITY, Calif. , Feb. 22, 2018 /PRNewswire/ --  Genomic Health, Inc.  (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Thursday, March 8 at 8:30 a.m. Eastern Time to discuss its fourth quarter and year-end 2017 financial results. The call and webcast